UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~April~~November 419, 2008

SUTURA, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-25548	84-1010269
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)
17080 Newhope Street, Fountain Valley, California		92708
(Address of principal executive offices)		(Zip Code)


Delaware (State or other jurisdiction of incorporation)		000-25548 (Commission File Number)		84-1010269 (IRS Employer Identification No.)


17080 Newhope Street, Fountain Valley, California (Address of principal executive offices)		92708 (Zip Code)

Registrant’s telephone number, including area code: (714) 437-9801

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

This Form 8-K, as well as other reports filed by the Registrant from time to time with the Securities and Exchange Commission (collectively the “Filings”), contain forward looking statements and information that are based upon beliefs of, and information currently available to, the Registrant’s management as well as estimates and assumptions made by the Registrant’s management. When used in the Filings the words “anticipate”, “believe”, “estimate”, “expect”, “intend”, “plan” or the negative of these terms and similar expressions as they relate to the Registrant or the Registrant’s management identify forward looking statements. Such statements reflect the current view of the Registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the Registrant’s industry, operations and results of operations and any businesses that may be acquired by the Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

Section 54 — ~~Corporate~~Matters ~~Governance~~Related to Accountants and ~~Management~~Financial Statements

Item 54.0102. ~~Changes~~Non-Reliance inon ~~Control~~Previously ofIssued ~~Registrant~~Financial Statements or a Related Audit Report or Completed Interim Review.

To On July 1, 2007, Registrant and the ~~extent~~Whitebox ~~required~~affiliated byparties ~~Item 5.01~~amended ofthe ~~Form~~Whitebox ~~8-K~~I, Whitebox ~~the~~II ~~information~~and ~~contained~~Whitebox III convertible notes. Included in orthe ~~incorporated~~amendments was an extension of the bymaturity ~~reference~~dates ~~into~~of ~~Item~~each of the notes until July 81, 2009, payment of a 3% consent fee, and a reduction to the conversion rate to $.0108 per share. At the time of ~~this~~the ~~Current~~amendment ~~Report~~of isthe ~~hereby~~notes, Registrant ~~incorporated~~determined bythat ~~reference~~there ~~into~~was ~~this~~no intrinsic value resulting from the reduction of the ~~Item 5~~conversion price to $.0108 and did not treat the amendments as new loans as the notes were amended and new notes were not issued.

~~Item 5.02.~~However, ~~Departure~~in ofresponse ~~Directors~~to ora ~~Principal~~comment ~~Officers;~~letter ~~Election~~received from the United States Securities and Exchange Commission (“SEC”) and discussions with the SEC Staff, Registrant has determined that the July 1st, 2007 extension and changes in the terms of ~~Directors;~~the ~~Appointment~~Whitebox Notes I, II and III should have been accounted for as new notes rather than extensions of ~~Principal~~existing ~~Officers~~notes per FASB EITF 96-17. Accordingly, certain balance sheet entries, loss figures and expense figures in the Registrant’s Quarterly Reports for the periods ended September 30, 2007, March 31, 2008 and June 30, 2008 should not be relied upon as indicated below. Further, the accumulated deficit amounts contained in Registrant’s Annual Report for the year-ended December 31, 2007 should not be relied upon as indicated below.

ToThe difference is the ~~extent~~immediate ~~required~~amortization byof ~~Item 5~~the $634,996 beneficial conversion feature on our books as of July 1st, 2007 rather than amortization per our original schedule.02 For purposes of Registrant’s ~~Form~~Quarterly ~~8-K~~Report for the period ending September 30, 2008, and for periods thereafter, the ~~information~~September 30, ~~contained~~2007 inoutstanding ornotes ~~incorporated~~payables will be increased by $634,996 and third quarter 2007 interest expenses also by ~~reference~~$634,996. ~~into~~The ~~Item~~effect of these corrections on the third quarter of 2007 was an increase in interest expenses from $998,992 to $1,633,988. The net loss from operations increased from $2,936,132 to $3,571,128. For the year to date end of September 2007, interest expenses increased from $3,182,660 to $ $3,817,656 and the net loss increased from $8,674,288 till $9,309,284.01 ofIn ~~this~~the ~~Current~~balance sheet for Registrant’s Annual Report isfor ~~hereby~~the ~~incorporated~~year ended December 31, 2007 accumulated deficit was increased by ~~reference~~$472,467 ~~into~~from ~~this Item 5~~$57,661,739 to $58,134,208.~~02.~~

~~Section 8~~Authorized —officers ~~Financial~~discussed ~~Statements~~with ~~and~~the ~~Exhibits~~Registrant’s independent accountant the matters disclosed in this Current Report.

Item 8.01. Other Events

At a Special Meeting of the Board of Directors of the Registrant (the “Board”) held on April 4, 2008, Dr. Brian Abraham was appointed as Chief Executive Officer of Registrant. Mr. Richard Bjorkman resigned from his position as interim Chief Executive Officer at the Special Meeting, but continues to serve as Registrant’s Chief Financial Officer and Vice President, Finance. At the same Special Meeting of the Board, John Crew, M.D. and Charles Terrell, Sr. resigned from the Board, and Dr. Brian Abraham, John Kopchik, Mark Strefling and Richard Vigilante were appointed as directors to fill the existing four vacancies on the Board. Mr. Strefling was appointed as Chairman of the Board. Dr. Anthony Nobles resigned as Chairman of the Board at that meeting, but continues to serve as Registrant’s President, Chief Operating Officer and Chief Scientific Officer.

Each of Messrs. Abraham, Kopchik, Strefling and Vigilante are employed by Whitebox Advisors, LLC and/or affiliates of Whitebox Advisors, LLC. Whitebox Advisors, LLC, is an SEC-registered investment adviser based in Minneapolis, MN with over $4 billion of assts under management and, through its affiliates, has over $28.0 million invested in Sutura.

Effective April 2, 2008, the following affiliates of Whitebox Advisors, LLC converted $5,213,262.50 of convertible debt and accrued interest held by those entities into an aggregate of 65,165,775 shares of the Company’s Common Stock, par value $0.001 per share, as indicated below:

		Whitebox Convertible Arbitrage Partners, L.P. –			25,859,437.5
		Whitebox Hedged High yield Partners, L.P. -			20,687,550
		Whitebox Intermarket Partners, L.P. -			8,275,012.5
		Pandora Select Partners, L.P. -			10,343,775

Effective immediately after the conversion, there are 337,816,037 shares of Registrant’s Common Stock outstanding, and Whitebox Advisors, LLC is the beneficial owner of 149,712,197 shares Registrant’s Common Stock and has rights to acquire up to an additional 264,026,064 shares of Registrant’s Common Stock upon exercise of warrants and rights to convert debt.

Section 9 — Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits

(a) Financial statements of business acquired. ~~Not applicable (b) Pro forma financial information. Not applicable~~

~~Exhibit Index~~ Not applicable

(cb) Pro ~~Exhibits.~~forma ~~None~~financial information.

Not applicable

Not Applicable

(d) Exhibits.

Not Applicable

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SUTURA, INC. (Registrant)
Date: April 10 , 2008	/s/ Dr. Brian Abraham
Date: November 19, 2008	/s/ Richard Bjorkman
	Dr. Brian Abraham
	Richard Bjorkman
	Chief Executive Officer
	Chief Financial Officer

Filing Compare · Sutura, Inc.